secwatch.observer — SEC 8-K summary
======================================

Issuer:     LianBio (LIANY)
CIK:        0001831283
Form:       8-K
Filed at:   2023-12-19T23:59:59+00:00
Accession:  0001831283-23-000137
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LianBio CEO Yizhe Wang resigns; Adam Stone named interim CEO; Board to update on strategic review in Q1 2024
--------------------------------------------------------------------------------

- CEO Yizhe Wang resigned effective Dec 16, 2023; receives severance of $1,525,000 plus accelerated vesting.
- Board appoints Adam Stone (Perceptive Advisors CIO) as interim CEO; no compensation for service.
- Board evaluating strategic alternatives; expects to communicate update in Q1 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831283/000183128323000137/0001831283-23-000137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831283/000183128323000137/lian-20231216.htm
  HTML page:      https://secwatch.observer/filing/0001831283-23-000137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer